Portfolio company
Rejuvenation Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops mRNA-based telomere extension therapies to treat patients with pulmonary fibrosis, liver disease, and other age-related conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Turn Biotechnologies
This company develops mRNA medicines and delivery platforms for cellular rejuvenation and tissue repair to treat age-related conditions for patients and pharmaceutical partners.
Telomere Therapeutics SL
This company develops telomerase gene therapies to treat idiopathic pulmonary fibrosis and other telomere-dysfunction syndromes for patients with unmet medical needs.
TURN BIO
This biotechnology company develops mRNA-based medicines to rejuvenate cells and treat age-related conditions for patients with dermatological, immunological, and osteoarthritic diseases.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
Rejuveron Life Sciences
This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.
RejuverSen
This biotechnology firm develops senolytic therapies to eliminate senescent cells for treating cancer, fibrosis and age-related diseases in humans.
Rejuveron Life Sciences AG
This biotechnology company develops regenerative therapies and medicines for patients with age-related diseases and vision loss.
Rejuveron
This biotechnology firm develops medicines and regenerative therapies targeting age-related diseases to improve healthspan for the aging population.
